The Claim
Elevated high-sensitivity C-reactive protein (hsCRP) is associated with a 43–68% increased risk of coronary heart disease in Black and White adults aged 45 and older, independent of triglyceride-to-HDL cholesterol levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults aged 45 and older with higher levels of high-sensitivity C-reactive protein have a 43–68% greater chance of developing coronary heart disease, regardless of their triglyceride-to-HDL cholesterol levels.
See the scientific wording
Elevated high-sensitivity C-reactive protein (hsCRP) is associated with a 43–68% increased risk of coronary heart disease in both Black and White adults aged 45 and older, regardless of triglyceride-to-HDL cholesterol levels, indicating inflammation is a consistent risk marker across races.
Persistent inflammation in the blood vessels causes the inner lining to become damaged, which allows fatty deposits to build up and harden into plaques. These plaques narrow the arteries and can suddenly rupture, triggering blood clots that block blood flow to the heart.
What the research says
1 studyThe study found that high levels of a blood marker for inflammation (hsCRP) predict a higher risk of heart disease in both Black and White adults over 45, no matter their cholesterol levels — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.